Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study

BackgroundA substantial portion of heart failure (HF) patients adherent to guideline-directed medical therapies have experienced improved ejection fraction (EF), termed HFimpEF. Glycemic variability (GV) has emerged as a critical cardiometabolic factor. However, the relation between long-term GV and...

Full description

Bibliographic Details
Main Authors: Chen Die Yang, Jia Wei Chen, Jin Wei Quan, Xin Yi Shu, Shuo Feng, Muladili Aihemaiti, Feng Hua Ding, Wei Feng Shen, Lin Lu, Rui Yan Zhang, Xiao Qun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1211954/full
_version_ 1827811946699685888
author Chen Die Yang
Jia Wei Chen
Jin Wei Quan
Xin Yi Shu
Shuo Feng
Muladili Aihemaiti
Feng Hua Ding
Wei Feng Shen
Wei Feng Shen
Lin Lu
Lin Lu
Rui Yan Zhang
Xiao Qun Wang
Xiao Qun Wang
author_facet Chen Die Yang
Jia Wei Chen
Jin Wei Quan
Xin Yi Shu
Shuo Feng
Muladili Aihemaiti
Feng Hua Ding
Wei Feng Shen
Wei Feng Shen
Lin Lu
Lin Lu
Rui Yan Zhang
Xiao Qun Wang
Xiao Qun Wang
author_sort Chen Die Yang
collection DOAJ
description BackgroundA substantial portion of heart failure (HF) patients adherent to guideline-directed medical therapies have experienced improved ejection fraction (EF), termed HFimpEF. Glycemic variability (GV) has emerged as a critical cardiometabolic factor. However, the relation between long-term GV and the incidence of HFimpEF is still unclear.MethodsA total of 591 hospitalized HF patients with reduced EF (HFrEF, EF≤ 40%) admitted from January 2013 to December 2020 were consecutively enrolled. Repeat echocardiograms were performed at baseline and after around 12 months. The incidence of HFimpEF, defined as (1) an absolute EF improvement ≥10% and (2) a second EF > 40% and its association with long-term fasting plasma glucose (FPG) variability were analyzed.ResultsDuring a mean follow-up of 12.2 ± 0.6 months, 218 (42.0%) patients developed HFimpEF. Multivariate analysis showed FPG variability was independently associated with the incidence of HFimpEF after adjustment for baseline HbA1c, mean FPG during follow-up and other traditional risk factors (odds ratio [OR] for highest vs. lowest quartile of CV of FPG: 0.487 [95% CI 0.257~0.910]). Evaluation of GV by alternative measures yielded similar results. Subgroup analysis revealed that long-term GV was associated with HFimpEF irrespective of glycemic levels and diabetic conditions.ConclusionsThis study reveals that greater FPG variability is associated with compromised development of HFimpEF. A more stable control of glycemic levels might provide favorable effects on myocardial functional recovery in HF patients even without diabetes.
first_indexed 2024-03-11T23:12:25Z
format Article
id doaj.art-604a509c4ba64226b0d775dc2d1241ba
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-11T23:12:25Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-604a509c4ba64226b0d775dc2d1241ba2023-09-21T07:20:18ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-09-011410.3389/fendo.2023.12119541211954Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort studyChen Die Yang0Jia Wei Chen1Jin Wei Quan2Xin Yi Shu3Shuo Feng4Muladili Aihemaiti5Feng Hua Ding6Wei Feng Shen7Wei Feng Shen8Lin Lu9Lin Lu10Rui Yan Zhang11Xiao Qun Wang12Xiao Qun Wang13Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaInstitute of Cardiovascular Disease, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaBackgroundA substantial portion of heart failure (HF) patients adherent to guideline-directed medical therapies have experienced improved ejection fraction (EF), termed HFimpEF. Glycemic variability (GV) has emerged as a critical cardiometabolic factor. However, the relation between long-term GV and the incidence of HFimpEF is still unclear.MethodsA total of 591 hospitalized HF patients with reduced EF (HFrEF, EF≤ 40%) admitted from January 2013 to December 2020 were consecutively enrolled. Repeat echocardiograms were performed at baseline and after around 12 months. The incidence of HFimpEF, defined as (1) an absolute EF improvement ≥10% and (2) a second EF > 40% and its association with long-term fasting plasma glucose (FPG) variability were analyzed.ResultsDuring a mean follow-up of 12.2 ± 0.6 months, 218 (42.0%) patients developed HFimpEF. Multivariate analysis showed FPG variability was independently associated with the incidence of HFimpEF after adjustment for baseline HbA1c, mean FPG during follow-up and other traditional risk factors (odds ratio [OR] for highest vs. lowest quartile of CV of FPG: 0.487 [95% CI 0.257~0.910]). Evaluation of GV by alternative measures yielded similar results. Subgroup analysis revealed that long-term GV was associated with HFimpEF irrespective of glycemic levels and diabetic conditions.ConclusionsThis study reveals that greater FPG variability is associated with compromised development of HFimpEF. A more stable control of glycemic levels might provide favorable effects on myocardial functional recovery in HF patients even without diabetes.https://www.frontiersin.org/articles/10.3389/fendo.2023.1211954/fullglycemic variabilityheart failure with improved ejection fractionheart failure with reduced ejection fractionmyocardial recoveryfasting plasma glucose
spellingShingle Chen Die Yang
Jia Wei Chen
Jin Wei Quan
Xin Yi Shu
Shuo Feng
Muladili Aihemaiti
Feng Hua Ding
Wei Feng Shen
Wei Feng Shen
Lin Lu
Lin Lu
Rui Yan Zhang
Xiao Qun Wang
Xiao Qun Wang
Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
Frontiers in Endocrinology
glycemic variability
heart failure with improved ejection fraction
heart failure with reduced ejection fraction
myocardial recovery
fasting plasma glucose
title Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
title_full Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
title_fullStr Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
title_full_unstemmed Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
title_short Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
title_sort long term glycemic variability predicts compromised development of heart failure with improved ejection fraction a cohort study
topic glycemic variability
heart failure with improved ejection fraction
heart failure with reduced ejection fraction
myocardial recovery
fasting plasma glucose
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1211954/full
work_keys_str_mv AT chendieyang longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT jiaweichen longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT jinweiquan longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT xinyishu longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT shuofeng longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT muladiliaihemaiti longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT fenghuading longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT weifengshen longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT weifengshen longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT linlu longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT linlu longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT ruiyanzhang longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT xiaoqunwang longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy
AT xiaoqunwang longtermglycemicvariabilitypredictscompromiseddevelopmentofheartfailurewithimprovedejectionfractionacohortstudy